Can-Fite Reports First Quarter 2022 Financial Results & Provides Clinical Update
Ryan Allway May 26th, 2022 News, Top News PETACH TIKVA, Israel, May 26, 2022–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended March... Read more
Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update
Ryan Allway August 26th, 2021 PETACH TIKVA, Israel, August 26, 2021–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended June 30, 2021. Corporate... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )